Ligustrazine Attenuates Myocardial Injury Induced by Coronary Microembolization in Rats by Activating the PI3K/Akt Pathway

Table 1

Changes in cardiac function ().

Group		LVEF (%)	LVFS (%)	CO (L/min)	LVEDd (mm)
Sham	10
CME	10	^a	^a	^a	^a
Ligustrazine	10	^ab	^ab	^ab	^ab
Ligustrazine+LY	10	^a	^a	^a	^a

CME: coronary microembolization; LVFS: left ventricle fractional shortening; LVEDd: left ventricular end-diastolic diameter; CO: cardiac output; LY: LY294002; LVEF: left ventricle ejection fraction. ^a compared with the sham group. ^b compared with the CME group.